Macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis with coronary involvement in a pre-school patient. Case report and literature review
Main Article Content
Abstract
DOI: 10.1016/j.rcpe.2015.11.001
Systemic juvenile idiopathic arthritis (SJIA) is one of the most common chronic diseases in children. In spite of having well-defined clinical manifestations, the diagnosis of SJIA remains a clinical challenge as it requires previously ruling out infectious, neoplastic or inflammatory type conditions, in the context of the patient with fever of unknown origin. Coronary involvement on SJIA has been demonstrated in about 10% of cases. The macrophage activation syndrome (MAS) is a complication of SJIA that can be potentially fatal if an appropriate approach and treatment is not performed.
The case concerns a pre-school infant with no significant medical history, with clinical symptoms of 12 days onset, characterised by intermittent fever, associated with cough, rhinorrhoea and skin manifestations (generalized exanthema) and oral cavity plaques. During clinical evolution, Kawasaki syndrome symptoms were considered, based on clinical criteria and subsequently supported by echocardiogram findings (dilation of coronary arteries). A total of 2 doses of human immunoglobulin were given, with no clear improvement in the clinical symptoms and laboratory parameters. Glucocorticoids and immunomodulatory management therapy was then started. The patient was finally diagnosed with a macrophage activation syndrome, based on laboratory parameters in the context of an autoimmune disease, such as systemic juvenile idiopathic arthritis. A satisfactory clinical outcome was obtained with outpatient treatment.
SJIA remains a disease that is difficult to diagnose early. To distinguish this entity from other rheumatological conditions, mainly Kawasaki disease, remains a diagnostic challenge in pediatrics. It requires great ability to recognize this disease and initiate its respective treatment in a timely manner in order to avoid fatal outcomes as a result of complications.
Downloads
Article Details
Creative Commons
License Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
You are free to:
Share - copy and redistribute the material in any medium or format.
Adapt - remix, transform, and build upon the material The licensor cannot revoke these freedoms as long as you follow the license terms.
• Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial — You may not use the material for commercial purposes.
• ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
• No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
References
Juvenile idiopathic arthritis presenting with prolonged fever
J Microbiol Immunol Infect., 43 (2010), pp. 169-174 http://dx.doi.org/10.1016/S1684-1182(10)60027-8
Medline
2 S. Dong,S. Bout-Tabaku,K. Texter,P. Jaggi
Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease
J Pediatr., 166 (2015), pp. 1283-1288 http://dx.doi.org/10.1016/j.jpeds.2015.02.003
Medline
3 F. Minoia,S. Davi,A. Horne,E. Demirkaya,F. Bovis,C. Li
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients
Arthritis Rheumatol., 66 (2014), pp. 3160-3169 http://dx.doi.org/10.1002/art.38802
Medline
4 E.M. Behrens,T. Beukelman,M. Paessler,R.Q. Cron
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis
J Rheumatol, 34 (2007), pp. 1133-1138
Medline
5 F. Minoia,S. Davì,A. Horne,E. Demirkaya,F. Bovis,C. Li
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients
Arthritis Rheumatol., 66 (2014), pp. 3160-3169 http://dx.doi.org/10.1002/art.38802
Medline
6 A. Lefèvre-Utile,C. Galeotti,I. Koné-Paut
Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis
Joint Bone Spine., 81 (2014), pp. 257-259 http://dx.doi.org/10.1016/j.jbspin.2013.09.004
Medline
7 S. Kumar,B. Vaidyanathan,S. Gayathri,L. Rajam
Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: Case report and literature review
Rheumatol Int., 33 (2013), pp. 1065-1069 http://dx.doi.org/10.1007/s00296-010-1650-8
Medline
8 J. Goldenberg,M.B. Ferraz,A.P. Pessoa,A.S. Fonseca,A.C. Carvalho,M.O. Hilario
Symptomatic cardiac involvement in juvenile rheumatoid arthritis
Int J Cardiol., 34 (1992), pp. 57-62
Medline
9 S. Dogra,A. Gehlot,D. Suri,A. Rawat,R.M. Kumar,S. Singh
Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis–the diagnostic dilemma
Indian J Pediatr., 80 (2013), pp. 783-785 http://dx.doi.org/10.1007/s12098-012-0893-7
Medline
10 D. Rigante,P. Valentini,R. Onesimo,D.F. Angelone,A. De Nisco,G. Bersani
Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome
Rheumatol Int., 30 (2010), pp. 535-539 http://dx.doi.org/10.1007/s00296-009-0960-1
Medline
11 A. Kelly,A.V. Ramanan
Recognition and management of macrophage activation syndrome in juvenile arthritis
Curr Opin Rheumatol., 19 (2007), pp. 477-481 http://dx.doi.org/10.1097/BOR.0b013e32825a6a79
Medline